Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated
Abstract Glioblastoma is the deadliest primary brain tumor, largely due to inevitable recurrence of the disease after treatment. While most recurrences are local, patients rarely present with a new discontiguous focus of glioblastoma. Little is currently known about the genetic profile of discontigu...
Saved in:
Main Authors: | Malcolm F. McDonald, Sricharan Gopakumar, Tareq A. Juratli, Ilker Y. Eyüpoglu, Ganesh Rao, Jacob J. Mandel, Ali Jalali |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40478-024-01900-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SOSIODEMOGRAPHIC FACTORS ON CONTRACEPTIVE USE AMONG MARRIED WOMAN: EVIDENCE FROM THREE INDONESIA DEMOGRAPHIC AND HEALTH SURVEY (IDHS)
by: Nur Faridah Latifah, et al.
Published: (2024-07-01) -
Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
by: Ximu Sun, et al.
Published: (2025-02-01) -
IDH-mutant gliomas in children and adolescents - from biology to clinical trials
by: Louise Evans, et al.
Published: (2025-01-01) -
Venetoclax and Azacitidine Combination is an Effective Salvage Regimen for Fit Patients with IDH-2-mutated Acute Myeloid Leukemia Refractory to Conventional Induction Chemotherapy
by: Musa Fares Alzahrani
Published: (2024-12-01) -
Dermoscopy of Periungual Papules in Multicentric Reticulohistiocytosis
by: José María Llamas-Molina, et al.
Published: (2025-01-01)